Zinereo aims to offer CDMO services of medicines and pharmaceutical-quality probiotics, tackling current human and animal health issues from a ground-breaking perspective. We are a dynamic company with over 80 years’ experience in drug development and manufacturing. We also have extensive knowledge of biotechnology applied to the control of microorganisms. Know-how and experience are the cornerstones of a unique value proposition that we can be found in our pharmaceutical-quality probiotics. We are members of the Advisory Council for 𝐒𝐄𝐌𝐢𝐏𝐲𝐏 (Spanish Society of Microbiota, Probiotics and Prebiotics)